我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Respiratory Mucosa in Patients with Chronic Obstructive Pulmonary Dysfunction

Kjell E J H

The vast majority of pulmonary medications are used to promote broncho-dilation and improve alveolar ventilation and oxygenation. These effects should improve an individual's ability to exercise and more effectively develop training effects. Because of the side effects of many pulmonary medications, however, exercise tolerance and the normal adaptations to habitual exercise conditioning may be retarded. The following section is not presented to discourage the use of these medications nor of exercise training; rather, it should highlight the important role exercise has for patients with pulmonary disease who are taking pulmonary medications.